Key result
The ArthroCaP study is an ongoing prospective cohort study evaluating the association between chronic postsurgical pain and postoperative cognitive dysfunction, with 46 patients enrolled to date.
Why the study?
Chronic postsurgical pain may increase the risk of postoperative cognitive dysfunction, but complex underlying mechanisms and associations with surgical satisfaction remain to be clarified.
Is chronic postsurgical pain at 6 months associated with postoperative cognitive dysfunction at 12 months in patients undergoing elective knee or hip arthroplasty?
Cohort (n=46)
Is chronic postsurgical pain at 6 months associated with postoperative cognitive dysfunction at 12 months in patients undergoing elective knee or hip arthroplasty?
The ArthroCaP study will provide prospective data on the association between chronic postsurgical pain and postoperative cognitive dysfunction after elective joint arthroplasty.
Background Chronic postsurgical pain (CPSP) may increase the risk of postoperative cognitive dysfunction (POCD) directly or by negatively impacting mobility. A comprehensive measure of satisfaction with surgery that accounts for ability to perform activities might be even more strongly associated with POCD. There might be complex mechanisms underlying the interplays between postoperative pain and cognition.Aims The primary objective is to explore whether CPSP at 6 months is associated with POCD (≥2-point decline in the Montreal Cognitive Assessment [MoCA] compared to preoperative) at 12 months. Secondary objectives are to explore the association between satisfaction with surgery and POCD, the role of pain medications (opioids) in the association between CPSP and POCD, the role of patient preoccupation/optimism and coping in determining the effect of pain on cognition, and the hypothesis of neurogenesis interference as an underlying mechanism.Methods We will prospectively recruit ≥100 patients ≥50 years old undergoing elective total knee/hip arthroplasty. Sociodemographic characteristics, comorbidities, frailty, pain, and pain medications will be assessed preoperatively. The Somatic Preoccupation and Coping questionnaire will be administered preoperatively and 4 to 6 weeks postoperative. Pain and the Self-Administered Patient Satisfaction Scale will be measured at 3 and 6 months. MoCA and neuropsychological tests will be administered at baseline, 4 to 6 weeks, and 6 and 12 months. Blood will be longitudinally collected for biomarker analysis.Progress Forty-six participants have been enrolled in the study so far.Conclusion ArthroCaP will provide preliminary data on the association of CPSP and patient satisfaction with POCD and underlying mechanisms. It will inform larger confirmatory and interventional studies to enhance the benefits of surgery.
No takes yet. Share an insight, caveat, or question.
Khaled et al. (2022) conducted a cohort in elective knee or hip arthroplasty (n=46). Chronic postsurgical pain (CPSP) at 6 months was evaluated on postoperative cognitive dysfunction (POCD) (≥2-point decline in the Montreal Cognitive Assessment [MoCA] compared to preoperative) at 12 months. The ArthroCaP study is an ongoing prospective cohort study evaluating the association between chronic postsurgical pain and postoperative cognitive dysfunction, with 46 patients enrolled to date.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: